Company Filing History:
3 out of 949 
1 out of 3,222 
Years Active: 2011-2023
Title: Mika Endo: Innovator in Cancer Treatment
Introduction
Mika Endo is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Endo's work focuses on developing novel therapeutic methods for combating various types of cancer.
Latest Patents
Endo's latest patents include groundbreaking methods for treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies. This invention provides compositions and methods for treating cancers by administering a PD-1 axis binding antagonist alongside an anti-GPC3 antibody. The pharmaceutical compositions are designed to enhance the efficacy of cancer treatment. Another notable patent involves a cell injury-inducing therapeutic drug for cancer therapy. This invention features anticancer agents that comprise a bispecific antibody, which enhances the affinity for two antigens, thereby improving anti-tumor activity and safety.
Career Highlights
Throughout his career, Mika Endo has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Genentech, Inc. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.
Collaborations
Endo has collaborated with esteemed colleagues, including Yasuko Kinoshita and Yumiko Kawai. These partnerships have played a crucial role in advancing his research and patent developments.
Conclusion
Mika Endo's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the field of oncology.